Website logo DLD News

Christina Nesheva

Close-up portrait of Christina Nesheva, Chair of the Board of Officinae Bio, smiling a the camera.

Officinae Bio

Christina Nesheva is the Chair of the Board of Officinae Bio, a techbio company pioneering precision design of DNA and RNA to drive the next generation of biotherapeutics. As CEO, she previously led the commercialization, fundraising and strategy from the early stages to the company’s acquisition by Maravai LifeSciences.

Full ProfileVideosEvents

Videos

Thomas Clozel, (OWKIN), Christina Nesheva, (Officinae Bio), Edward Shenderovich, (Synonym) and Azeem Azhar, (Exponential View) on stage at the DLD Munich Conference 2025, with audience members visible in the foreground.

Biology’s ChatGPT Moment

AI-driven innovation in biotech, medicine and material science promises a transition from a fossil-based economy to a more sustainable. Moderated by Azeem Azhar (Exponential View), this DLD25 expert panel discussion brings together Christina Nesheva…
Video details

Events

DLD25 graphic design

DLD Munich 2025

Europe’s leading innovation conference celebrates its 20th anniversary from January 16-18, 2025, in Munich. Find out about speakers, location details and how to attend…
Event details
All SpeakersVideo Archive
magnifiercrosschevron-downmenu-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram